1 / 70

Strategizing for mHealth: Insights, Challenges, and Paths Forward

This document distills key insights from interviews and process reviews on mHealth interventions and their strategic implications. It highlights the current challenges faced in scaling mHealth initiatives, the roles of various stakeholders, and the need for better alignment between internal capabilities and external strategies. A special focus is placed on the D-tree product strategy, competitive analysis, and the evolving mHealth ecosystem. Recommendations aim to guide future development and address funding models, while understanding the significant impact of partnerships and user needs.

shani
Download Presentation

Strategizing for mHealth: Insights, Challenges, and Paths Forward

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Strategy Planning Process

  2. Agenda • Interviews (JESS) • mHealthecosystem (RYA) • D-tree product strategy (TOGETHER) • D-tree business model (RYA) • Creating internal alignment (JESS) • Strategy definition process (RYA) • Elephants (TOGETHER) • Appendix Week 1: Product and Process Review v. 1.0

  3. Interviews: What we heard

  4. Mix between believers and skeptics in potential of mhealth Week 1: Product and Process Review v. 1.0

  5. mHealth interventions encounter similar problems in scale and siloing Week 1: Product and Process Review v. 1.0

  6. Major players clearly identified by interviewees Week 1: Product and Process Review v. 1.0

  7. Agreement over role of partnerships… Week 1: Product and Process Review v. 1.0

  8. And some agreement about role of different sectors • But general feeling that current players unable to bring to scale alone or at all Week 1: Product and Process Review v. 1.0

  9. Differing ideas about greatest area of need • CHW vs. Facility • Communication vs. logistics Week 1: Product and Process Review v. 1.0

  10. Inconsistent views of D-tree Week 1: Product and Process Review v. 1.0

  11. mHealth ecosystem Week 1: Product and Process Review v. 1.0

  12. mHealth hitting every part of health system • Health system diagram with examples

  13. In the middle of a bubble Week 1: Product and Process Review v. 1.0

  14. Scale rarely yet achieved, with some exceptions Week 1: Product and Process Review v. 1.0

  15. Not significant focus on impact at present Week 1: Product and Process Review v. 1.0

  16. Increasing entrance of major players Week 1: Product and Process Review v. 1.0

  17. Case study: Novartis / SMS for Life Week 1: Product and Process Review v. 1.0

  18. Case study: Grameen Intel Week 1: Product and Process Review v. 1.0

  19. Funding still remains essential simple models and sustainability not yet cracked Week 1: Product and Process Review v. 1.0

  20. D-tree Product Strategy

  21. Current D-tree portfolio and competitive advantage • And why this is not strongest it could Week 1: Product and Process Review v. 1.0

  22. Create focus and expertise • Key decision areas

  23. Solutions provider vs. discrete product/service Week 1: Product and Process Review v. 1.0

  24. Target end user: CHW vs. Facility CHW

  25. Protocols: expertise?

  26. Software: Develop or contract

  27. Hardware • Cannot scale and be hardware supporter

  28. Implementation and Training Week 1: Product and Process Review v. 1.0

  29. Evaluating points of impact Week 1: Product and Process Review v. 1.0

  30. Geography Week 1: Product and Process Review v. 1.0

  31. Recommendations Week 1: Product and Process Review v. 1.0

  32. Competitive analysis • With strong competitors prodcut differentiation important Week 1: Product and Process Review v. 1.0

  33. Designing the system Don’t know where go • Incentives • Frontline provider • Doctor • Patient • Tracking—what happens after referral • Evaluation • Measuring impact Week 1: Product and Process Review v. 1.0

  34. Possible growth and development trajectories Don’t know where go Week 1: Product and Process Review v. 1.0

  35. Possible roadblocks Don’t know where go • Protocols hard to sell • NGOs/gov’t management Week 1: Product and Process Review v. 1.0

  36. Business models

  37. Recognized sources of funding for healthcare

  38. Provider models • Pay point of care • Subcontract as systems specialist • Develop own clinics • Clinic in a phone—entrepreneur, franchise • Bricks and mortar • Telemedicine

  39. Provider model analysis Week 1: Product and Process Review v. 1.0

  40. Payor models • Insurance • Government • National • Foreign • NGOs Week 1: Product and Process Review v. 1.0

  41. Payor model analysis Week 1: Product and Process Review v. 1.0

  42. Medical research models • Pharma • Government • National • Foreign • UN/WHO? • University Week 1: Product and Process Review v. 1.0

  43. Research model analysis Week 1: Product and Process Review v. 1.0

  44. Adjacent industries • Telecomm • Hardware • Software Week 1: Product and Process Review v. 1.0

  45. Telecomm Analysis Relevance to D-tree Week 1: Product and Process Review v. 1.0 Direct revenue Access to markets

  46. Hardware/Software

  47. Conclusions

  48. Internal alignment to external strategy

  49. Necessary capabilities

  50. Roles Week 1: Product and Process Review v. 1.0

More Related